Health
Humans tend to move faster when they think they're going to get a reward. A new experiment explores the pathways in the brain that may be behind these patterns.
Doctoral student William Frantz is developing microscopic droplets designed to help doctors track radiation therapy in real time. His pitch at the Lab Venture Challenge highlighted how the technology could make cancer treatment more precise and less harmful, particularly for pediatric patients.
The ¶¶ÒõÂÃÐÐÉä Boulder biochemist has been awarded for her career dedication to the study of nucleosomes and groundbreaking discoveries.
Toxic protein clusters known as tau aggregates underlie dozens of neurodegenerative diseases, or "tauopathies." New research illuminates why they form and spread and how to stop them.
Sanna Darvish discusses the interventions her research has identified to improve heart health and the steps the Integrative Physiology of Aging Laboratory has taken to address accessibility challenges for people in underrepresented groups.
New research shows that a little-known brain pathway plays a critical role in making pain last after tissue heals. The findings could help pave the way for new brain-machine interfaces and medications that ease suffering without the use of opioids.
¶¶ÒõÂÃÐÐÉä Boulder joins Medtronic in strategic partnership to drive breakthrough health innovations¶¶ÒõÂÃÐÐÉä Boulder and two other ¶¶ÒõÂÃÐÐÉä campuses have been chosen from a nationwide search to partner with Medtronic—a global leader in health care technology—in a strategic research agreement aimed at accelerating transformative health innovations.
A new device, designed by researchers at ¶¶ÒõÂÃÐÐÉä Boulder and ¶¶ÒõÂÃÐÐÉä Anschutz, jiggles red blood cells until they break apart—revealing valuable information about their quality.
The Nobel laureate and ¶¶ÒõÂÃÐÐÉä Boulder professor, recently ranked #1 globally for RNA research, will speak at the World Economic Forum annual meeting in Davos, Switzerland Wednesday.
In an ongoing effort to bridge a pervasive investment gap in innovation funding, ¶¶ÒõÂÃÐÐÉä Boulder has awarded pre-seed funding to Illumen Therapeutics, developing cancer treatments based on discoveries from startup co-founder Roy Parker's lab at ¶¶ÒõÂÃÐÐÉä Boulder.